| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.027 | 0.7 |